Radioimmunoassay
Ref. Range : <15% of inhibition

Clinical Significance
Myasthenia gravis (MG) is a neuromuscular disorder charactarized
by muscle weakness, most commonly due to autoantibody-mediated
loss of functional acetylcholine receptors (AChr) in the neuromuscular
junction.  This assay is most useful when the acetylcholinesterase
receptor modulating antibodies are positive.  The assay for blocking
antibodies is useful in monitoring response to therapy.

Specimen Container:
No additive (red top)

1.0 (0.2) ml serum
Transfer serum to plastic, screw top vial.
Serum is the only acceptable sample.

Transport at room temperature

CPT Code : 83519

Performed: referred-A
turnaround: 3-5 days